Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Dong, Hua ^a,b   Luo, Li ^b   Hong, Shengjun ^a   Siu, Hoicheong ^a   Xiao, Yanghua ^a   Jin, Li ^a   Chen, Rui ^c   Xiong, Momiao ^a,b  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MICRORNA;

ANIMAL; ARTICLE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETICS; GENOMICS; GLIOBLASTOMA; HETEROZYGOSITY LOSS; HUMAN; METABOLISM; METHODOLOGY; MOUSE; MUTATION; SYSTEMS BIOLOGY;

ANIMALS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENOMICS; GLIOBLASTOMA; HUMANS; LOSS OF HETEROZYGOSITY; MICE; MICRORNAS; MUTATION; RNA, MESSENGER; SYSTEMS BIOLOGY;

EID: 78649348286     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-163     Document Type: Article

References (68)

1. Lipsitz D, Higgins RJ, Kortz GD, Dickinson PJ, Bollen AW, Naydan DK, LeCouteur RA. Glioblastoma multiforme: clinical findings, magnetic resonance imaging, and pathology in five dogs. Vet Pathol 2003, 40:659-669. 10.1354/vp.40-6-659, 14608019.
2. Mischel PS, Nelson SF, Cloughesy TF. Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy. Cancer Biol Ther 2003, 2:242-247.
3. Krex D, Klink B, Hartmann C, von Deimling A, Pietsch T, Simon M, Sabel M, Steinbach JP, Heese O, Reifenberger G, et al. Long-term survival with glioblastoma multiforme. Brain 2007, 130:2596-2606. 10.1093/brain/awm204, 17785346.
4. The Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455:1061-1068. 10.1038/nature07385, 2671642, 18772890, The Cancer Genome Atlas Research Network.
5. Gennarino VA, Sardiello M, Avellino R, Meola N, Maselli V, Anand S, Cutillo L, Ballabio A, Banfi S. MicroRNA target prediction by expression analysis of host genes. Genome Res 2009, 19:481-490. 10.1101/gr.084129.108, 2661810, 19088304.
6. Maziere P, Enright AJ. Prediction of microRNA targets. Drug Discov Today 2007, 12:452-458. 10.1016/j.drudis.2007.04.002, 17532529.
7. Yang Y, Wang YP, Li KB. MiRTif: a support vector machine-based microRNA target interaction filter. BMC Bioinformatics 2008, 9(Suppl 12):S4. 10.1186/1471-2105-9-S12-S4, 2638144, 19091027.
8. Michaelson JJ, Loguercio S, Beyer A. Detection and interpretation of expression quantitative trait loci (eQTL). Methods 2009, 48:265-276. 10.1016/j.ymeth.2009.03.004, 19303049.
9. Dartnell L, Simeonidis E, Hubank M, Tsoka S, Bogle ID, Papageorgiou LG. Robustness of the p53 network and biological hackers. FEBS Lett 2005, 579:3037-3042. 10.1016/j.febslet.2005.03.101, 15896791.
10. Demetrius L, Manke T. Robustness and network evolution-an entropic principle. Physica A: Statistical Mechanics and its Applications 2005, 346:682.
11. Azzopardi D, Dallosso AR, Eliason K, Hendrickson BC, Jones N, Rawstorne E, Colley J, Moskvina V, Frye C, Sampson JR, et al. Multiple rare nonsynonymous variants in the adenomatous polyposis coli gene predispose to colorectal adenomas. Cancer Res 2008, 68:358-363. 10.1158/0008-5472.CAN-07-5733, 18199528.
12. Madsen BE, Browning SR. A groupwise association test for rare mutations using a weighted sum statistic. PLoS Genet 2009, 5:e1000384. 10.1371/journal.pgen.1000384, 2633048, 19214210.
13. Xiong M, Zhao J, Boerwinkle E. Generalized T2 test for genome association studies. Am J Hum Genet 2002, 70:1257-1268. 10.1086/340392, 447600, 11923914.
14. Li B, Leal SM. Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet 2008, 83:311-321. 10.1016/j.ajhg.2008.06.024, 2842185, 18691683.
15. Joyce P, Tavare S. The distribution of rare alleles. J Math Biol 1995, 33:602-618. 10.1007/BF00298645, 7608640.
16. Maglott D, Ostell J, Pruitt KD, Tatusova T. Entrez Gene: gene-centered information at NCBI. Nucleic Acids Res 2007, 35:D26-31. 10.1093/nar/gkl993, 1761442, 17148475.
17. Liang P, Pardee AB. Analysing differential gene expression in cancer. Nat Rev Cancer 2003, 3:869-876. 10.1038/nrc1214, 14668817.
18. Knorn F. Ranking schemes. In Ranking and importance in complex networks. 2005, Kildare Ireland: National University of Ireland Maynooth, Co.
19. El Hallani S, Ducray F, Idbaih A, Marie Y, Boisselier B, Colin C, Laigle-Donadey F, Rodero M, Chinot O, Thillet J, et al. TP53 codon 72 polymorphism is associated with age at onset of glioblastoma. Neurology 2009, 72:332-336. 10.1212/01.wnl.0000341277.74885.ec, 19171829.
20. Imoto I, Pimkhaokham A, Watanabe T, Saito-Ohara F, Soeda E, Inazawa J. Amplification and overexpression of TGIF2, a novel homeobox gene of the TALE superclass, in ovarian cancer cell lines. Biochem Biophys Res Commun 2000, 276:264-270. 10.1006/bbrc.2000.3449, 11006116.
21. Yang HS, Cho MH, Zakowicz H, Hegamyer G, Sonenberg N, Colburn NH. A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 2004, 24:3894-3906. 10.1128/MCB.24.9.3894-3906.2004, 387765, 15082783.
22. Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J, et al. Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer 2007, 7:55. 10.1186/1471-2407-7-55, 1852112, 17389037.
23. Helleman J, Jansen MP, Span PN, van Staveren IL, Massuger LF, Meijer-van Gelder ME, Sweep FC, Ewing PC, van der Burg ME, Stoter G, et al. Molecular profiling of platinum resistant ovarian cancer. Int J Cancer 2006, 118:1963-1971. 10.1002/ijc.21599, 16287073.
24. Sethi T, Rintoul RC, Moore SM, MacKinnon AC, Salter D, Choo C, Chilvers ER, Dransfield I, Donnelly SC, Strieter R, Haslett C. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: a mechanism for small cell lung cancer growth and drug resistance in vivo. Nat Med 1999, 5:662-668. 10.1038/9511, 10371505.
25. Cimino G, Sprovieri T, Rapanotti MC, Foa R, Mecucci C, Mandelli F. Molecular evaluation of the NUP98/RAP1GDS1 gene frequency in adults with T-acute lymphoblastic leukemia. Haematologica 2001, 86:436-437.
26. Hussey DJ, Nicola M, Moore S, Peters GB, Dobrovic A. The (4;11)(q21;p15) translocation fuses the NUP98 and RAP1GDS1 genes and is recurrent in T-cell acute lymphocytic leukemia. Blood 1999, 94:2072-2079.
27. Forch P, Valcarcel J. Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1. Apoptosis 2001, 6:463-468. 10.1023/A:1012441824719, 11595836.
28. Brooks AS, Bertoli-Avella AM, Burzynski GM, Breedveld GJ, Osinga J, Boven LG, Hurst JA, Mancini GM, Lequin MH, de Coo RF, et al. Homozygous nonsense mutations in KIAA1279 are associated with malformations of the central and enteric nervous systems. Am J Hum Genet 2005, 77:120-126. 10.1086/431244, 1226183, 15883926.
29. Sun S, Ning X, Liu J, Liu L, Chen Y, Han S, Zhang Y, Liang J, Wu K, Fan D. Overexpressed CacyBP/SIP leads to the suppression of growth in renal cell carcinoma. Biochem Biophys Res Commun 2007, 356:864-871. 10.1016/j.bbrc.2007.03.080, 17400182.
30. Ning X, Sun S, Hong L, Liang J, Liu L, Han S, Liu Z, Shi Y, Li Y, Gong W, et al. Calcyclin-binding protein inhibits proliferation, tumorigenicity, and invasion of gastric cancer. Mol Cancer Res 2007, 5:1254-1262. 10.1158/1541-7786.MCR-06-0426, 18171983.
31. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4:44-57. 10.1038/nprot.2008.211, 19131956.
32. Huang JC, Babak T, Corson TW, Chua G, Khan S, Gallie BL, Hughes TR, Blencowe BJ, Frey BJ, Morris QD. Using expression profiling data to identify human microRNA targets. Nat Methods 2007, 4:1045-1049. 10.1038/nmeth1130, 18026111.
33. Zhang L, Volinia S, Bonome T, Calin GA, Greshock J, Yang N, Liu CG, Giannakakis A, Alexiou P, Hasegawa K, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA 2008, 105:7004-7009. 10.1073/pnas.0801615105, 2383982, 18458333.
34. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y. miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res 2009, 37:D98-104. 10.1093/nar/gkn714, 2686559, 18927107.
35. Volinia S, Galasso M, Costinean S, Tagliavini L, Gamberoni G, Drusco A, Marchesini J, Mascellani N, Sana ME, Abu Jarour R, et al. Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010, 20:589-599. 10.1101/gr.098046.109, 2860161, 20439436.
36. Guo AY, Sun J, Jia P, Zhao Z. A novel microRNA and transcription factor mediated regulatory network in schizophrenia. BMC Syst Biol 2010, 4:10. 10.1186/1752-0509-4-10, 2834616, 20156358.
37. Song F, Zheng H, Liu B, Wei S, Dai H, Zhang L, Calin GA, Hao X, Wei Q, Zhang W, Chen K. An miR-502-binding site single-nucleotide polymorphism in the 3'-untranslated region of the SET8 gene is associated with early age of breast cancer onset. Clin Cancer Res 2009, 15:6292-6300. 10.1158/1078-0432.CCR-09-0826, 19789321.
38. Cox DR. Regression models and life-tables. J Roy Statist Soc SerB Methodological 1972, 34:24.
39. Sassen S, Miska EA, Caldas C. MicroRNA: implications for cancer. Virchows Arch 2008, 452:1-10. 10.1007/s00428-007-0532-2, 2151131, 18040713.
40. Megraw M, Sethupathy P, Corda B, Hatzigeorgiou AG. miRGen: a database for the study of animal microRNA genomic organization and function. Nucleic Acids Res 2007, 35:D149-155. 10.1093/nar/gkl904, 1669779, 17108354.
41. Sethupathy P, Corda B, Hatzigeorgiou AG. TarBase: A comprehensive database of experimentally supported animal microRNA targets. RNA 2006, 12:192-197. 10.1261/rna.2239606, 1370898, 16373484.
42. Karginov FV, Conaco C, Xuan Z, Schmidt BH, Parker JS, Mandel G, Hannon GJ. A biochemical approach to identifying microRNA targets. Proc Natl Acad Sci USA 2007, 104:19291-19296. 10.1073/pnas.0709971104, 2148283, 18042700.
43. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63. 10.1038/nature07228, 18668040.
44. Yang Y, Chaerkady R, Beer MA, Mendell JT, Pandey A. Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach. Proteomics 2009, 9:1374-1384. 10.1002/pmic.200800551, 19253296.
45. Carpenter B, Hill KJ, Charalambous M, Wagner KJ, Lahiri D, James DI, Andersen JS, Schumacher V, Royer-Pokora B, Mann M, et al. BASP1 is a transcriptional cosuppressor for the Wilms' tumor suppressor protein WT1. Mol Cell Biol 2004, 24:537-549. 10.1128/MCB.24.2.537-549.2004, 343806, 14701728.
46. Mingorance A, Soriano-Garcia E, del Rio JA. [Nogo-A functions during the development of the central nervous system and in the adult]. Rev Neurol 2004, 39:440-446.
47. Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 2007, 81:12836-12845. 10.1128/JVI.01804-07, 2169101, 17881434.
48. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G, Capogrossi MC, Martelli F. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008, 283:15878-15883. 10.1074/jbc.M800731200, 18417479.
49. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Proc Natl Acad Sci USA 2008, 105:5874-5878. 10.1073/pnas.0801130105, 2311339, 18390668.
50. Li Z, Hassan MQ, Jafferji M, Aqeilan RI, Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS, Lian JB. Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009, 284:15676-15684. 10.1074/jbc.M809787200, 2708864, 19342382.
51. Rayner KJ, Suarez Y, Davalos A, Parathath S, Fitzgerald ML, Tamehiro N, Fisher EA, Moore KJ, Fernandez-Hernando C. MiR-33 contributes to the regulation of cholesterol homeostasis. Science 2010, 328:1570-1573. 10.1126/science.1189862, 20466885.
52. Herrera-Merchan A, Cerrato C, Luengo G, Dominguez O, Piris MA, Serrano M, Gonzalez S. miR-33-mediated downregulation of p53 controls hematopoietic stem cell self-renewal. Cell Cycle 2010, 9:3277-3285. 10.4161/cc.9.16.12598, 20703086.
53. Pacifico F, Paolillo M, Chiappetta G, Crescenzi E, Arena S, Scaloni A, Monaco M, Vascotto C, Tell G, Formisano S, Leonardi A. RbAp48 is a target of nuclear factor-kappaB activity in thyroid cancer. J Clin Endocrinol Metab 2007, 92:1458-1466. 10.1210/jc.2006-2199, 17244783.
54. Caligo MA, Cipollini G, Berti A, Viacava P, Collecchi P, Bevilacqua G. NM23 gene expression in human breast carcinomas: loss of correlation with cell proliferation in the advanced phase of tumor progression. Int J Cancer 1997, 74:102-111. 10.1002/(SICI)1097-0215(19970220)74:1<102::AID-IJC18>3.0.CO;2-H, 9036878.
55. Hagedorn M, Delugin M, Abraldes I, Allain N, Belaud-Rotureau MA, Turmo M, Prigent C, Loiseau H, Bikfalvi A, Javerzat S. FBXW7/hCDC4 controls glioma cell proliferation in vitro and is a prognostic marker for survival in glioblastoma patients. Cell Div 2007, 2:9. 10.1186/1747-1028-2-9, 1819378, 17326833.
56. Heraud C, Chevrier L, Meunier AC, Muller JM, Chadeneau C. Vasoactive intestinal peptide-induced neuritogenesis in neuroblastoma SH-SY5Y cells involves SNAP-25. Neuropeptides 2008, 42:611-621. 10.1016/j.npep.2008.05.005, 18617262.
57. Wang C, Li N, Liu X, Zheng Y, Cao X. A novel endogenous human CaMKII inhibitory protein suppresses tumor growth by inducing cell cycle arrest via p27 stabilization. J Biol Chem 2008, 283:11565-11574. 10.1074/jbc.M800436200, 2431061, 18305109.
58. Hansen CN, Ketabi Z, Rosenstierne MW, Palle C, Boesen HC, Norrild B. Expression of CPEB, GAPDH and U6snRNA in cervical and ovarian tissue during cancer development. APMIS 2009, 117:53-59. 10.1111/j.1600-0463.2008.00015.x, 19161537.
59. Namkoong J, Shin SS, Lee HJ, Marin YE, Wall BA, Goydos JS, Chen S. Metabotropic glutamate receptor 1 and glutamate signaling in human melanoma. Cancer Res 2007, 67:2298-2305. 10.1158/0008-5472.CAN-06-3665, 17332361.
60. Anglesio MS, Arnold JM, George J, Tinker AV, Tothill R, Waddell N, Simms L, Locandro B, Fereday S, Traficante N, et al. Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors. Mol Cancer Res 2008, 6:1678-1690. 10.1158/1541-7786.MCR-08-0193, 19010816.
61. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007, 446:153-158. 10.1038/nature05610, 2712719, 17344846.
62. Wood LD, Parsons DW, Jones S, Lin J, Sjoblom T, Leary RJ, Shen D, Boca SM, Barber T, Ptak J, et al. The genomic landscapes of human breast and colorectal cancers. Science 2007, 318:1108-1113. 10.1126/science.1145720, 17932254.
63. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et al. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812. 10.1126/science.1164382, 2820389, 18772396.
64. Rubin AF, Green P. Comment on "The consensus coding sequences of human breast and colorectal cancers". Science 2007, 317:1500. 10.1126/science.1138956, 17872429.
65. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, et al. MicroRNA signature predicts survival and relapse in lung cancer. Cancer Cell 2008, 13:48-57. 10.1016/j.ccr.2007.12.008, 18167339.
66. Peng J, Wang P, Zhou NF, Zhu J. Partial correlation estimation by joint sparse regression model. Journal of the American Statistical Association 2009, 104:735. 10.1198/jasa.2009.0126, 2770199, 19881892.
67. Langfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: the Dynamic Tree Cut package for R. Bioinformatics 2008, 24:719-720. 10.1093/bioinformatics/btm563, 18024473.
68. Hashimoto K, Goto S, Kawano S, Aoki-Kinoshita KF, Ueda N, Hamajima M, Kawasaki T, Kanehisa M. KEGG as a glycome informatics resource. Glycobiology 2006, 16:63R-70R. 10.1093/glycob/cwj010, 16014746.